+ Primordial Genetics presents at BIO World Congress on Industrial Biotechnology conference in Philadelphia, PA Sabrina Baffert, July 16, 2018February 28, 2020, News, 0
Primordial Genetics receives NIH Grant: Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease Sabrina Baffert, January 1, 2018February 19, 2020, News, 0 The principal aim of this project is to apply a novel synthetic biology approach to develop protein expression strains...
Primordial Genetics launches enzyme improvement project for pharmaceutical manufacturing. Sabrina Baffert, November 18, 2015February 19, 2020, News, 0 This week, Primordial Genetics signed a Letter of Intent with a San Diego-based pharmaceutical company (‘Company A’), for a...
+ Poster presentation at the BIO World Congress on Industrial Biotechnology by Justin Stege, Director of Industrial Biotechnology Sabrina Baffert, April 18, 2016February 28, 2020, News, 0
Primordial Genetics closes new financing round and adds private equity investors Sabrina Baffert, January 1, 2015February 19, 2020, News, 0 Primordial Genetics today announced the first closing of its Series A-2 financing round, including a group of 5 private...
Primordial Genetics presents at Synthetic Biology, Engineering, Evolution and Design (SEED) conference in Scottsdale, AZ Sabrina Baffert, June 3, 2018February 20, 2020, News, 0
Primordial Genetics signs R&D Agreement for pharmaceutical manufacturing. Sabrina Baffert, March 30, 2016February 19, 2020, News, 0 Following the launch of an R&D project for improvement of an enzyme used for manufacturing high-value pharmaceuticals in November...
Investor presentation at the 2015 BIO 12th Annual World Congress on Industrial Biotechnology Sabrina Baffert, July 20, 2015February 20, 2020, News, 0